MedPath

Prevalence of Hypertension in Type-2 Diabetes Mellitus

Completed
Conditions
Prevalence of Elevated Blood Pressure in Type-2 Diabetics
Registration Number
NCT05266885
Lead Sponsor
Kabul University of Medical Sciences
Brief Summary

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

Detailed Description

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

This is a descriptive cross-sectional study, which included 322 type -2 diabetic patients (37 male, 63 female) who were presented to our center from November 2019 to January 2020.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
322
Inclusion Criteria
  • Clinically diagnosed diabetic patients
  • Newly diagnosed Diabetics
  • known case of diabetes
Exclusion Criteria
  • The patients who were seriously ill
  • Pregnant women
  • Type-1 diabetic patients,

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
High incidence of HTN in Diabetics3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Habib Ahmad Esmat

🇦🇫

Kabul, None Selected, Afghanistan

Habib Ahmad Esmat
🇦🇫Kabul, None Selected, Afghanistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.